As a pre-screen strategy to identify which of these members was important to predict HCC outcome, we searched for a correlation between the gene expression of each member of the TIGIT/DNAM-1 axis and DFS and OS data. The gene discussed is CD226; the disease is hepatocellular carcinoma.